Lavanya Ponnusamy

Berberine and Emodin abrogates breast cancer growth and facilitates apoptosis through inactivation of SIK3-induced mTOR and Akt signaling pathway.

Lavanya Ponnusamy, G. Kothandan, R. Manoharan, 2020, Biochimica et biophysica acta. Molecular basis of disease.

MELK/MPK38 in cancer: from mechanistic aspects to therapeutic strategies.

Lavanya Ponnusamy, R. Manoharan, Karthik Thangaraj, 2020, Drug discovery today.

Therapeutic aspects of AMPK in breast cancer: Progress, challenges, and future directions.

Lavanya Ponnusamy, R. Manoharan, Karthik Thangaraj, 2020, Biochimica et biophysica acta. Reviews on cancer.

Distinctive role of SIK1 and SIK3 isoforms in aerobic glycolysis and cell growth of breast cancer through the regulation of p53 and mTOR signaling pathways.

Lavanya Ponnusamy, R. Manoharan, 2021, Biochimica et biophysica acta. Molecular cell research.

Epigenetic regulation of miR-200 as the potential strategy for the therapy against triple-negative breast cancer.

Lavanya Ponnusamy, S. Naushad, M. Pal‐Bhadra, 2018, Gene.

MARK2/4 promotes Warburg effect and cell growth in non-small cell lung carcinoma through the AMPKα1/mTOR/HIF-1α signaling pathway.

Lavanya Ponnusamy, R. Manoharan, S. Natarajan, 2022, Biochimica et biophysica acta. Molecular cell research.